Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 1, 2013, Pages 55-62

  Aaltonen, Kalle J ^a,b   Virkki, Liisa M ^b   Jämsen, Esa ^c   Sokka, Tuulikki ^d   Konttinen, Yrjö T ^b,c,e,f   Peltomaa, Ritva ^f   Tuompo, Riitta ^f   Yli Kerttula, Timo ^g   Kortelainen, Saara ^h   Ahokas Tuohinto, Pirkko ⁱ   Blom, Marja ^a   Nordström, Dan C ^f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d Central Finland Central Hospital   (Finland)

^e ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g Rauma Regional Hospital   (Finland)

^h TURKU UNIVERSITY HOSPITAL   (Finland)

ⁱ Raahe Hospital   (Finland)

Author keywords

Biologicals; Disease modifying anti rheumatic drugs (DMARDs); Epidemiology; Orthopedics; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; BIOLOGICAL PRODUCT; CERTOLIZUMAB PEGOL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TOCILIZUMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FINLAND; FOLLOW UP; HUMAN; INCIDENCE; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS SURVIVAL; REGISTER; REOPERATION; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

BIOLOGICALS; DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS); EPIDEMIOLOGY; ORTHOPEDICS; RHEUMATOID ARTHRITIS;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT; BIOLOGICAL PRODUCTS; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; TREATMENT OUTCOME;

EID: 84881559248     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.01.002     Document Type: Article

References (23)

1. Wolfe F., Zwillich S.H. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum 1998, 41(6):1072-1082.
2. Fevang B.T.S., Lie S.A., Havelin L.I., Engesaeter L.B., Furnes O. Reduction in orthopedic surgery among patients with chronic inflammatory joint disease in Norway, 1994-2004. Arthritis Rheum 2007, 57(3):529-532.
3. Sokka T., Kautiainen H., Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann Rheum Dis 2007, 66(3):341-344.
4. Momohara S., Inoue E., Ikari K., Kawamura K., Tsukahara S., Iwamoto T., et al. Decrease in orthopaedic operations, including total joint replacements, in patients with rheumatoid arthritis between 2001 and 2007: data from Japanese outpatients in a single institute-based large observational cohort (IORRA). Ann Rheum Dis 2010, 69(1):312-313.
5. De Piano L.P.A., Golmia R.P., Scheinberg M.A. Decreased need of large joint replacement in patients with rheumatoid arthritis in a specialized Brazilian center. Clin Rheumatol 2011, 30(4):549-550.
6. Hekmat K., Jacobsson L., Nilsson J.-Å., Petersson I.F., Robertsson O., Garellick G., et al. Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis-results from a well defined population in south Sweden. Arthritis Res Ther 2011, 13(2):R67. [BioMed Central Ltd].
7. Kononoff A., Heiskanen J., Lumiaho J., Kautiainen H., Kaipiainen-Seppänen O. Intensifying treatment of rheumatoid arthritis with combinations of traditional disease-modifying anti-rheumatic drugs among patients with persistent disease did not reduce the need for large joint surgery. Scand J Rheumatol 2007, 36(6):424-427.
8. Graudal N., Jürgens G. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons. Arthritis Rheum 2010, 62(10):2852-2863.
9. Rud-Sørensen C., Pedersen A.B., Johnsen S.P., Riis A.H., Overgaard S. Survival of primary total hip arthroplasty in rheumatoid arthritis patients. Acta Orthop 2010, 81(1):60-65.
10. Jämsen E., Huotari K., Huhtala H., Nevalainen J., Konttinen Y.T. Low rate of infected knee replacements in a nationwide series-is it an underestimate?. Acta Orthop 2009, 80(2):205-212.
11. Eskelinen A., Paavolainen P., Helenius I., Pulkkinen P., Remes V. Total hip arthroplasty for rheumatoid arthritis in younger patients: 2557 replacements in the Finnish arthroplasty register followed for 0-24 years. Acta Orthop 2006, 77(6):853-865.
12. Breedveld F.C., Kalden J.R. Appropriate and effective management of rheumatoid arthritis. Ann Rheum Dis 2004, 63(6):627-633.
13. Bongartz T., Halligan C.S., Osmon D.R., Reinalda M.S., Bamlet W.R., Crowson C.S., et al. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 2008, 59(12):1713-1720.
14. Pieringer H., Stuby U., Biesenbach G. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment?. Semin Arthritis Rheum 2007, 36(5):278-286.
15. Saag K.G., Teng G.G., Patkar N.M., Anuntiyo J., Finney C., Curtis J.R., et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008, 59(6):762-784.
16. Revell P.A.. The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface 2008, 5(28):1263-1278.
17. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3):315-324.
18. Virkki L., Aaltonen K., Nordström D.C. Biologiset reumalääkkeet-käytännön kokemukset rekisteritulosten valossa. Duodecim 2010, 126:1487-1495. [in Finnish].
19. Sokka T. Rheumatoid arthritis databases in Finland. Clin Exp Rheumatol 2005, 23(5 Suppl. 39):S201-S204.
20. Puolakka T.J., Pajamäki K.J., Halonen P.J., Pulkkinen P.O., Paavolainen P., Nevalainen J.K. The Finnish arthroplasty register: report of the hip register. Acta Orthop Scand 2001, 72(5):433-441.
21. Forsström J, Perälä A Lonkka- ja polviproteesit Suomessa 2009. THL (National Institute for Health and Welfare); 2011 [in Finnish].
22. Rosenbaum P.R., Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70(1):41.
23. Pope J.E., Khanna D., Norrie D., Ouimet J.M. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol 2009, 36(2):254-259.